Belgium

About Statistics Publications & Documents Information by Topic

Note pour Eco-Santé OCDE 2009: Belgique

pdf,121Kb,French |  View long abstract

01-Jul-2009

Les dépenses de santé totales représentaient en Belgique 10.2% du PIB en 2007, soit 1 point de pourcentage de plus que la moyenne des pays de l’OCDE (8.9%).

A System of Health Accounts: Implementation - Belgium

English |  View long abstract

12-Jan-2009

Information on the status of implementation of OECD's A System of Health Accounts in Belgium.

Current Developments in Nanotechnology in Belgium

pdf,90Kb,English |  View long abstract

07-Apr-2008

This paper, which was submitted by the Belgian delegation, shows the current developments in nanotechnology in Belgium, given at the 3rd Meeting of the Working Party on Manufactured Nanomaterials, held ...

Trends in Severe Disability Among Elderly People (Health Working Paper No. 26)

pdf,615Kb,English |  View long abstract

30-Mar-2007

Gaétan Lafortune, Gaëlle Balestat

As the number and share of the population aged 65 and over will continue to grow steadily in OECD countries over the next decades, improvements in the functional status of elderly people could help mitigate the rise in the demand for, and hence expenditure on, long-term care.

Creation and Governance of Human Genetic Research Databases

English |  View long abstract

31-Oct-2006

Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.

Note pour Eco-Santé OCDE 2006: BELGIQUE

pdf,146Kb,French |  View long abstract

26-Jun-2006

Les dépenses de santé totales représentaient en Belgique 10.1% du PIB en 2003, soit 1.2 points de pourcentage de plus que la moyenne des pays de l’OCDE (8.9%).

Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level

English |  View long abstract

31-Mar-2006

This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.

Economic Survey - Belgium 2005: Constraining public health expenditure growth

English |  View long abstract

09-Mar-2005

High growth in healthcare expenditures continues to pose a risk to the sustainability of public finances. Recent measures to control the level of aggregate spending should be strengthened.